CDC Panel Firing: Vaccine Maker Uncertainty
- has fired all members of the Centers for Disease Control and Prevention’s vaccine advisory committee. The move casts uncertainty over the future of vaccine recommendations and vaccine safety...
- Kennedy explained his decision in a Wall Street Journal op-ed,stating the dismissals aim to "re-establish public confidence in vaccine science" by removing conflicts of interest.
- The HHS has not yet announced the new panel members.
HHS Secretary Kennedy’s decisive firing of the CDC’s vaccine advisory panel immediately injects uncertainty into future vaccine recommendations and overall vaccine safety protocols. This bold move, driven by a desire to restore public trust and eliminate conflicts of interest, raises critical questions. Analysts are already expressing concerns that the replacement panel members might align with Kennedy’s views on vaccines, which would considerably impact the vaccine development space. The upcoming advisory meeting on COVID-19 vaccines—scheduled for late June—is now under immense scrutiny. News Directory 3 is closely following this story. Discover what’s next in this evolving saga of public health and policy.
HHS Secretary Kennedy Fires Vaccine Panel,Citing Safety Concerns
Updated June 10,2025
Health and human Services Secretary Robert F. Kennedy Jr. has fired all members of the Centers for Disease Control and Prevention’s vaccine advisory committee. The move casts uncertainty over the future of vaccine recommendations and vaccine safety protocols.
Kennedy explained his decision in a Wall Street Journal op-ed,stating the dismissals aim to “re-establish public confidence in vaccine science” by removing conflicts of interest. However, analysts suggest Kennedy’s replacements could share his skepticism about vaccines.
The HHS has not yet announced the new panel members. Despite the changes, an advisory meeting on June 25-27 remains scheduled to discuss recommendations for COVID-19 vaccines and other shots.
The abrupt dismissal of the 17 members of the Advisory Committee on Immunization Practices (ACIP) adds to existing pressures on vaccine manufacturers. The ACIP, comprised of self-reliant public health experts, advises the CDC director on vaccine recommendations. Their guidance determines which vaccines insurers must cover and which shots are included in the Vaccines for Children Program.
Richard Hughes, a lawyer with Epstein Becker Green, noted the move ends a 64-year period of the committee guiding federal vaccine policy.
William Blair analyst Myles Minter called the action a “hindrance to the vaccine development space,” suggesting new members might have stricter views on vaccine uptake. Daina Graybosch, an analyst at Leerink Partners, speculated future panelists might share some of Kennedy’s views regarding the alleged dangers of vaccines.
Sen. Bill Cassidy, R-La.,expressed concern that the ACIP will be filled with individuals who are suspicious of vaccines. He said he spoke with Kennedy to ensure this does not happen.
What’s next
The selection of new ACIP members will be closely watched by the pharmaceutical industry and public health officials, as it will likely signal the direction of future vaccine policy and recommendations.